Extracellular vesicles as a source for non-invasive biomarkers in bladder cancer progression

详细信息    查看全文

• 作者：Zoraida Andreu^a ; Renan Otta Oshiro^b ; Alberto Redruello^a ; Soraya Ló ; pez-Mart&iacute ; n^a ; Cristina Gutié ; rrez-Vá ; zquez^c ; ^d ; ^e ; ^f ; Esperanza Morato^e ; Ana Isabel Marina^e ; Carlos Olivier Gó ; mez^b ; Mar&iacute ; a Yá ; ñ ; ez-Mó ; ^a ; ^f ; ^{maria.yanez@salud.madrid.org} ; ^{maria.yannez@uam.es}
• 关键词：Extracellular vesicles ; Bladder cancer ; Urine ; MicroRNAs ; Proteomics ; Apo B
• 刊名：European Journal of Pharmaceutical Sciences
• 出版年：2017
• 出版时间：15 February 2017
• 年：2017
• 卷：98
• 期：Complete
• 页码：70-79
• 全文大小：1388 K
• 卷排序：98

文摘

Bladder cancer is the second most frequent malignancy of the urinary tract after prostate cancer. Current diagnostic techniques, such as cystoscopy and biopsies are highly invasive and accompanied of undesirable side effects. Moreover, there are no suitable biomarkers for relapse or progression prognosis. We analysed whether the specific composition of microRNAs (miRNAs) and proteins of extracellular vesicles (EVs) that urothelial tumour cells of bladder mucosa release into the urine, could reflect their pathologic condition. For this purpose, urinary EVs were isolated and their protein and miRNA composition evaluated in healthy donors and low or high-grade bladder cancer patients. Using a microarray platform containing probes for 851 human miRNAs we found 26 deregulated miRNAs in high-grade bladder cancer urine EVs, from which 23 were downregulated and 3 upregulated. Real-time PCR analysis pointed to miR-375 as a biomarker for high-grade bladder cancer while miR-146a could identify low-grade patients. Finally, several protein markers were also deregulated in EVs from tumour patients. Our data suggest that the presence of ApoB in the 100,000 pellet is a clear marker for malignancy.